
|Videos|May 30, 2023
Risk Stratification of Patients with Prostate Cancer
Michael Cookson, MD, MMHC, explains the NCCN criteria used to stratify patients with clinically localized prostate cancer into risk groups.
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
2
FDA approves first-line Zenflow system for the treatment of BPH
3
FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women
4
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
5






















